Canopy Growth (CGC) Stock
Key stats
- Market cap
- $285.85M
- Price / Earnings ratio
- -1.9x
- EPS (TTM)
- -$0.50
- Volume
- Loading
- 52-week high
- $2.38
- 52-week low
- $0.64
- EPS vs analyst estimate
- +90.9%Q2 FY26 · -$0.01 vs -$0.11
Source: third-party data provider, as of November 7, 2026
EPS estimate: analyst consensus
Compare with CGC
Recent news

Canopy Growth vs. Tilray Brands: Quarterly Revenue Scale and Consistency in Cannabis
Canopy Growth vs. Tilray Brands: Quarterly Revenue Scale and Consistency in Cannabis
CGC

Canopy Growth Corporation (CGC) is Attracting Investor Attention: Here is What You Should Know
Canopy Growth Corporation (CGC) is Attracting Investor Attention: Here is What You Should Know
CGC

Canopy Growth Corporation (CGC) Beats Stock Market Upswing: What Investors Need to Know
Canopy Growth Corporation (CGC) Beats Stock Market Upswing: What Investors Need to Know
CGC

Canopy Growth Announces Results of 2026 Annual General and Special Meeting of Shareholders
Canopy Growth Announces Results of 2026 Annual General and Special Meeting of Shareholders
CGC
News tone: automated (AI) classification of the article's content, not a price prediction.
Technical indicators
- RSI 14
- 38.40
- MACD 12/26/9
- -0.04
- EMA 9 of MACD
- -0.05
- MACD histogram
- 0.01
- SMA 50
- $0.84
- Price below SMA 50
- EMA 50
- $0.81
- Price below EMA 50
- SMA 200
- $0.99
- Price below SMA 200
- EMA 200
- $0.99
- Price below EMA 200
Calculated by Gotrade from daily closing prices, as of November 5, 2026. Technical data, not a recommendation.
Analyst ratings
No analyst data available
Financials
Performance
Debt & Balance Sheet
Revenue to Profit
2026Earnings
The market is expecting earnings per share of -$0.01 for this quarter. The company has not yet shared when it is announcing earnings.
Source: third-party data provider
Latest news

Canopy Growth vs. Tilray Brands: Quarterly Revenue Scale and Consistency in Cannabis
Canopy Growth vs. Tilray Brands: Quarterly Revenue Scale and Consistency in Cannabis
CGC

Canopy Growth Corporation (CGC) is Attracting Investor Attention: Here is What You Should Know
Canopy Growth Corporation (CGC) is Attracting Investor Attention: Here is What You Should Know
CGC

Canopy Growth Corporation (CGC) Beats Stock Market Upswing: What Investors Need to Know
Canopy Growth Corporation (CGC) Beats Stock Market Upswing: What Investors Need to Know
CGC

Canopy Growth Announces Results of 2026 Annual General and Special Meeting of Shareholders
Canopy Growth Announces Results of 2026 Annual General and Special Meeting of Shareholders
CGC

Canopy Growth Shareholders Approve Reverse Split Authority, Elect Board
Canopy Growth Shareholders Approve Reverse Split Authority, Elect Board
CGC

Canopy Growth to Report Second Quarter Fiscal 2027 Financial Results on November 6, 2026
Canopy Growth to Report Second Quarter Fiscal 2027 Financial Results on November 6, 2026
CGC

Canopy Growth Corporation (CGC) Stock Declines While Market Improves: Some Information for Investors
Canopy Growth Corporation (CGC) Stock Declines While Market Improves: Some Information for Investors
CGC

Trump's Marijuana Order Is Stuck at the DEA. Here's What That Means for Canopy Growth.
Trump's Marijuana Order Is Stuck at the DEA. Here's What That Means for Canopy Growth.
CGC

Canopy Growth vs. Tilray Brands: Which Cannabis Stock Is a Better Buy in 2026?
Canopy Growth vs. Tilray Brands: Which Cannabis Stock Is a Better Buy in 2026?
CGC

Here's Why Canopy Growth Corporation (CGC) Fell More Than Broader Market
Here's Why Canopy Growth Corporation (CGC) Fell More Than Broader Market
CGC
News tone: automated (AI) classification of the article's content, not a price prediction.
About Canopy Growth
Canopy Growth is a world-leading diversified cannabis and cannabinoid-based consumer product company, driven by a passion to improve lives, end prohibition, and strengthen communities by unleashing the full potential of cannabis. Leveraging consumer insights and innovation, we offer product varieties in high-quality dried flower, oil, softgel capsule, infused beverage, edible, and topical formats, as well as vaporizer devices by Canopy Growth and industry-leader Storz & Bickel. Our global medical brand, Spectrum Therapeutics, sells a range of full-spectrum products using its colour-coded classification system and is a market leader in both Canada and Germany.
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Luc Mongeau | CEO & Director | 1967 |
| Mr. Thomas Carlton Stewart CPA | Chief Accounting Officer & CFO | 1982 |
| Dr. Christelle Gedeon L.L.B., Ph.D. | Chief Business Development & Corporate Affairs Officer | 1982 |
| Ms. Chrissy McHardy | Senior Vice President of Human Resources | — |
| Jason Green | Head of Agriculture - Hemp Division | — |
| Mr. Andrew Bevan | President of Medical Sales | — |
| Mr. Miles Worne | Managing Director of European Markets | — |
| Mr. David Manner | Managing Director of Storz & Bickel GmbH | — |
| Mr. Christopher Roach | Senior Vice President of Supply Chain & Transformation | — |
| Ms. Megan Amber McCrae | President of Canada Adult Use | — |
Fundamentals
Valuation
Profitability
Trading
Source: third-party data provider, as of November 7, 2026
Technical indicators
- RSI 14
- 38.40
- MACD 12/26/9
- -0.04
- EMA 9 of MACD
- -0.05
- MACD histogram
- 0.01
- SMA 50
- $0.84
- Price below SMA 50
- EMA 50
- $0.81
- Price below EMA 50
- SMA 200
- $0.99
- Price below SMA 200
- EMA 200
- $0.99
- Price below EMA 200
Calculated by Gotrade from daily closing prices, as of November 5, 2026. Technical data, not a recommendation.
Analyst views
No analyst data available
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | -17.5 | -12.2 | ||||||||||
| 2022 | -13.5 | -16.6 | +9.2 | -22.5 | -17.9 | -39.5 | -6.4 | +45.5 | -22.4 | +28.2 | +3.7 | -41.2 |
| 2023 | +31.2 | -25.3 | -22.2 | -23.1 | -35.3 | -53.5 | -16.4 | +21.2 | +42.4 | -23.3 | +1.3 | -17.3 |
| 2024 | -2.5 | -34.6 | +168.8 | +97.6 | -25.4 | -19.6 | +18.9 | -23.0 | -4.4 | +4.1 | -20.4 | -27.9 |
| 2025 | -30.9 | -28.9 | -26.6 | +35.3 | -6.4 | +0.8 | -8.8 | +71.4 | -2.0 | -10.1 | -2.5 | +0.9 |
| 2026 | -8.4 | +2.8 | -11.2 | +14.4 | -3.5 | -12.0 | -3.2 | +4.2 | -8.2 | -26.1 | +0.0 |
Corporate actions
Upcoming
No upcoming corporate actions for CGC



